Chronic kidney disease (CKD) cases have increased significantly in New Jersey, according to a new analysis by the New Jersey Hospital Association (NJHA). The prevalence of CKD among hospital patients has risen by nearly 60% since 2016, based on data reviewed by NJHA’s Center for Health Analytics, Research and Transformation (CHART).
The report indicates that the increase in CKD diagnoses affects all age groups, genders, and racial and ethnic communities across the state. However, Black residents in New Jersey experience a higher mortality rate from CKD compared to other groups.
CKD is characterized by progressive damage and reduced function of the kidneys. It is associated with chronic conditions such as diabetes, high blood pressure, and obesity. These factors are believed to contribute significantly to the rise in CKD cases. In its advanced stages, CKD can result in kidney failure that may require dialysis or transplantation.
The NJHA analyzed hospital discharge records from 2016 through 2024 to identify trends related to CKD diagnoses. Age-adjusted death rates were also assessed using data from the New Jersey State Health Assessment Data (NJSHAD) system.
NJHA President and CEO Cathy Bennett commented on the findings: “The complex picture surrounding CKD – rising incidence and improved mortality rates overall – may be shaped by improved diagnosis and treatment for CKD,” said Bennett. “But the disparate impact for Black New Jerseyans demands greater attention to issues of access, equity and the social factors that impact health in our communities.”
Additional details from this data analysis and other CHART reports are available at www.njha.com/CHART.
